The European network of Biosafety-Level-4 laboratories: Enhancing European preparedness for new health threats

Clinical Microbiology and Infection

Volumn 15, Issue 8, 2009, Pages 720-726

  Nisii, C ^a   Castilletti, C ^a   Di Caro, A ^a   Capobianchi, M R ^a   Brown, D ^b   Lloyd, G ^c   Gunther, S ^d   Lundkvist, A ^e   Pletschette, M ^f   Ippolito, G ^a   Drosten, C ^d   Falk, K ^e   Georges, M C ^g   Meyer, H ^h   Becker, S ⁱ   Eickmann, M ⁱ   Huemer, H ^j   Charrel, R ^k  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f EUROPEAN COMMISSION   (Belgium)

^g INSERM   (France)

^h BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

^j AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^k AIX MARSEILLE UNIVERSITY   (France)

more..

Author keywords

Biosafety; BSL 4 facilities; Emerging infectious diseases; Laboratory diagnosis

Indexed keywords

BIOSAFETY; EPIDEMIC; EUROPE; HEALTH CARE PLANNING; HUMAN; INFECTION; LABORATORY; LABORATORY DIAGNOSIS; MEDICAL SOCIETY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STANDARDIZATION; STRATEGIC PLANNING; TERRORISM; VIRUS DIAGNOSIS;

EID: 69249084105     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02946.x     Document Type: Review

References (60)

1. Morens DM, Fokers GK, Fauci A. The challenge of emerging and re-emerging infectious diseases. Nature 2004; 430: 242-249.
2. Hirschberg R, La Montagne J, Fauci AS. Biomedical Research -an integral component of National Security. N Engl J Med 2004; 350: 21.
3. Centers for Disease Control and Prevention. Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin. MMWR 2003; 52: 537-540
4. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349(25): 2431-2441.
5. ENIVD. European Network for the diagnosis of Imported Viral Diseases. European Commission, DG health and consumer protection. Available from: http://ec.europa.eu/health/ph_threats/com/networks/network_enivd_en.htm and http://www.enivd.de.
6. EUNID. European Network of Infectious Disease physicians. European Commission, DG health and consumer protection. Available from: http://ec.europa.eu/health/ph_projects/2003/action2/ action2_2003_04_en.htm and http://www.eunid.com.
7. EURONHID. European Network of highly infectious diseases. European Commission, Public Health Executive Agency. Available from: http://ec.europa.eu/phea/documents/2007_5986_EN.pdf and http://www.eunid.com.
8. ETHREAT. European training for health professionals on rapid responses to health threats. European Commission, DG health and consumer protection. Available from: http://ec.europa.eu/health/ph_projects/2004/ action2/action2_2004_02_en.htm.
9. ETIDE. European training for infectious disease emergencies. European Commission, DG health and consumer protection. Available from: http://ec.europa.eu/health/ph_projects/2005/action2/action2_2005_2_en.htm and http://www.etide.eu.
10. RiViGene. Genomic inventory, forensic markers, and assessment of potential therapeutic and vaccine targets for viruses relevant in biological crime and terrorism. DG Research 2005. Information available from: http://www15.bni-hamburg.de/bni/others/rivigene/.
11. VHF-Variola PCR. Development and commercial production of standardized PCR-assays for the detection of hemorrhagic fever viruses and variola virus and their implementation in the diagnostic service of EU P4 laboratories. European Commission, 6th Framework Programme on Research and technological development. Available from: http://cordis.europa.eu/ fetch?CALLER=FP6_PROJ&ACTION=D&DOC=1&CAT=PROJ&QUERY= 1183048901657&RCN=73904.
12. Biosafety Europe. Coordination, harmonization and exchange of Biosafety and biosecurity practices within a pan-european network. European Commission, 6th Framework Programme on Research and technological development. Available from: http://www.Ebsaweb.eu/Biosafety_Europe.html.
13. EURONET-P4. The European Network of P4 laboratories 2005-2007. European Commission, DG Sanco and consumer protection. Available from: http://ec.europa.eu/health/ph_projects/2003/action2/ action2_2003_19_en.htm and http://www.euronetp4.com.
14. ENP4-Lab. The European Network of P4 laboratories 2007-2010. European Commission, Public Health Executive Agency. Available from: http://ec.europa.eu/phea/documents/2007_5986_EN.pdf and http://www.euronetp4.com.
15. National Institutes of Health. What are Biosafety Labs? Bethesda, Md: National Institute of Allergy and Infectious Diseases. Available at: http://www3.niaid.nih.gov/Biodefense/Public/Biolab.htm.
16. World Health Organisation. Laboratory Biosafety Manual, 2nd (revised) edn. Interim guidelines 2003. WHO/CDS/CSR/LYO/2003.4. Available from: http://www.who.int/csr/resources/publications/biosafety/ who_cds_csr_lyo_20034/en/.
17. US Department of health and Human Services, Public Health Service, Centers for Disease Control and Prevention and national Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th edn. Washington, DC: US Government Printing Office, 2007.
18. Council Directive 90/679/EEC of 26 November 1990 on the protection of workers from risks related to exposure to biological agents at work. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri= CELEX:31990L0679:EN:HTML.
19. Directive 2000/54/EC of the European Parliament and of the Council of 18 September2000 on the protection of workers from risks related to exposure to biological agents at work. Available from: http://europa.eu/ eur-lex/pri/en/oj/dat/2000/l_262/l_26220001017en00210045.pdf.
20. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public Health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8: 225-230.
21. Gronvall GK, Fitzgerald J, Chamberlain A, Inglesby TV, O'Toole T. High containment biodefense research laboratories: Meeting report and center recommendations. Biosecur Bioterror 2005; 5: 75-85.
22. Steinbrook R. Research in the Hot Zone. N Engl J Med 2006; 354: 2.
23. Richardson L. Buying biosafety -is the price right? N Engl J Med 2004; 350: 21.
24. Thacker PD. 'Hot'labs take on dangerous pathogens. JAMA 2003; 290: 875-877.
25. Feldmann H, Czub M, Jones S et al. Emerging and re-emerging infectious diseases. Med Microbiol Immunol 2002; 191: 63-74.
26. Fouchier RA, Rimmelzwaan GF, Kuiken T, Osterhaus AD. Newer respiratory virus infections: Human metapneumovirus, avian influenza virus, and human coronaviruses. Curr Opin Infect Dis 2005; 18: 141-146.
27. Fauci AS. Emerging and re-emerging infectious disease: The perpetual challenge. Acad Med 2005; 80: 1079-1085.
28. World Health Organization. Disease outbreaks reported: Ebola hemorrhagic fever in Uganda. Wkly Epidemiol Rec 2000; 42: 337-338.
29. World Health Organization. Outbreak(s) of Ebola haemorrhagic fever in the Republic of Congo, January-April 2003. Wkly Epidemiol Rec 2003; 78: 285-289.
30. Centers for Disease Control and Prevention. Outbreak of Marburg virus hemorrhagic fever -Angola, October 1, 2004 -March 29, 2005. Morb Mortal Wkly Rep 2005; 54: 308-309.
31. World Health Organization. Marburg virus disease, Angola. Wkly Epidemiol Rec 2005; 80: 115-117.
32. World Health Organization. Ebola haemorrhagic fever in Uganda. http://www.who.int/csr/don/2007_11_30a/en/index.html.
33. Health Protection Agency. CDR Weekly, 23 September 2004; 14: 39. Available from: http://www.hpa.org.uk/cdr/archives/2004/cdr3904.pdf.
34. Pro Med-mail. Ebola, lab accident death. Archive number: 20040522. 1377, 22 May 2004. Boston, MA: International Society for Infectious Diseases. Available from: http://www.promedmail.org.
35. Unit for Surveillance and Communcation, Unit for Preparedness and Response (Editorial team). Case of Lassa fever imported into Germany from sierra Leone (E-alert 24 July). Euro Surveill 2006; 11: 3008. Avaliable from: http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=3008.
36. Pro Med - mail. Marburg Hemorrhagic Fever - The Netherlands ex Uganda. Archive number: 20080711.2 115, 11 July 2008. Boston, MA: International Society for Infectious Diseases. Available from: http://www.promedmail.org.
37. Kitching A, Addiman S, Cathcart S et al. A fatal case of Lassa fever in London, January 2009. Euro Surveill 2009; 14: 17-19.
38. Centers for Disease Prevention and Control (online). Outbreak Notice Update: 2008: Marburg Hemorrhagic fever, imported case - United States, 22 January 2009. Available from: http://www.cdc.gov/ncidod/dvrd/spb/ outbreaks/index.htm#USA.
39. Atkin S, Anaraki S, Gothard P, et al. The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill 2009; 14: 19145.
40. Haas WH, Breuer T, Pfaff G et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003; 36: 1254-1258.
41. Gunther S, Emmerich P, Laue T et al. Imported Lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis 2000; 6: 466-476.
42. Rota PA, Oberste MS, Monroe SS et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394-1399.
43. Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967-1976.
44. Choi KW, Chau TN, Tsang O et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003; 139: 715-723.
45. Guan Y, Zheng BJ, He YQ et al. Isolation and characterisation of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302: 276-278.
46. Drosten C, Kummerer BM, Schmitz H, Gunther S. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 2003; 57: 61-87.
47. Strong JE, Grolla A, Jahrling PB, Feldmann H. Filoviruses and arenaviruses. In: Detrick B, Hamilton RG, Folds JD, eds, Manual of molecular and clinical laboratory immunology. Washington, DC: ASM Press, 2006; 774-790.
48. Niedrig M, Niklassson B, Lloyd G, Schmitz H, LeGuenno B. Establishing a European network for the diagnosis of 'imported'viral diseases (ENIVD). Euro Surveill H998; 3: 80. Available from: http://www.eurosurveillance.org/em/v03n07/0307-223.asp.
49. Wolfel R, Paweska JT, Petersen N et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 2007; 13: 1097-1100.
50. Zhai J, Palacios G, Towner JS et al. Rapid molecular strategy for filovirus detection and characterization. J Clin Microbiol 2007; 45: 224-226.
51. Niedrig M, Meyer H, Panning M, Drosten C. Follow-up on diagnostic proficiency of laboratories equipped to perform orthopoxvirus detection and quantification by PCR: The second international external quality assurance study. J Clin Microbiol 2006; 44: 1283-1287.
52. Niedrig M, Leitmeyer K, Lim W, Peiris M, Mackenzie JS, Zambon M. First external quality assurance of antibody diagnostic for SARS-new coronavirus. J Clin Virol 2005; 34: 22-25.
53. Donoso MantkeO, Schmitz H, Zeller H, Heyman P, Papa A, Niedrig M; European Network for Diagnostics of Imported Viral Diseases (ENIVD). Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill 2005; 10: 102-106.
54. Centers for Disease Control and Prevention, National Institutes of health. Biosafety in microbiological and biomedical laboratories (BMBL), 4th edn. Washington, DC: Government Printing Office, 1999. http://www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4toc.htm.
55. Committee on Research Standards to prevent the destructive application of biotechnology, National Research Council. Biotechnology research in an age of terrorism. Washington, DC: National Academies Press, 2004.
56. Onyango CO, Opoka ML, Ksiazek TG et al. Laboratory diagnosis of Ebola haermorrhagic Fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 2007; 196: S193-S198.
57. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of haemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007; 196: S205-S212.
58. Towner JS, Khristova ML, Sealy TK et al. Marburgvirus genomics and association with a large haemorrhagic fever outbreak in Angola. J Virol 2006; 80: 6497-6516.
59. Grolla A, Lucht A, Dick D, Strong JE, Feldmann H. Laboratory diagnosis of Ebola and Marburg haemorrhagic fever. Bull Soc Pathol Exot 2005; 98: 205-209.
60. Towner JS, Rollin PE, Bausch DG et al. Rapid diagnosis of Ebola haemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78: 4330-4341.